Equilab International is a leading Contract Research Organization (CRO) in Southeast Asia who provides bioavailability/bioequivalence study, clinical trial and analytical services. As the first CRO in Southeast Asia that is certified by WHO and UK-MHRA, we are in compliance with international GCP and GLP standards. Our study reports have been approved in UK, Netherland, Poland, Spain, Hungary, Afghanistan, Sri Lanka, Bangladesh, Hong Kong, Taiwan, and all Southeast Asia countries. Currently, we are also involved in global trials for Covid-19 vaccine studies. Our existing customers come from Asia, Australia, Africa, America, Europe, and MNC's global.
View Top Employees from Equilab International| Website | http://equilab-int.com |
| Revenue | $15.9 million |
| Employees | 85 (56 on RocketReach) |
| Founded | 2003 |
| Address | 33 Jl. Rs. Fatmawati Persil, Jakarta 12430, ID |
| Phone | +62 21 7695513 |
| Technologies |
JavaScript,
PHP,
Nginx
+4 more
(view full list)
|
| Industry | Research Services, Drug Stores & Pharmacies, Retail |
| SIC | SIC Code 807 Companies, SIC Code 80 Companies |
| NAICS | NAICS Code 62 Companies, NAICS Code 6215 Companies, NAICS Code 62151 Companies, NAICS Code 621 Companies |
Looking for a particular Equilab International employee's phone or email?
Equilab International Questions
The Equilab International annual revenue was $15.9 million in 2024.
Wimala Widjaja is the Director of Equilab International.
56 people are employed at Equilab International.
The NAICS codes for Equilab International are [62, 6215, 62151, 621].
The SIC codes for Equilab International are [807, 80].
Top Equilab International Employees
Related Companies
